血压计市场机会、成长动力、产业趋势分析与预测 2024 - 2032

2023 年，全球血压计市场价值 34 亿美元，由于心臟病发病率上升、技术进步以及创新产品的不断推出，预计 2024 年至 2032 年复合年增长率为 8.5%。随着高血压变得越来越普遍，对准确可靠的血压监测设备的需求不断增长。具有自动读数和连接功能的数位血压计等技术创新可增强使用者体验和资料管理。此外，设计和功能的不断改进使这些设备更易于使用和高效，进一步推动市场在临床和家庭环境中的扩张。

血压计产业根据产品、操作、配置、最终用途和地区进行划分。由于其用户友好的设计和更高的准确性，数位血压计细分市场到 2023 年将达到 20 亿美元。数位设备提供自动读数，消除了手动错误并提供更快的结果，这使得它们对医疗保健专业人员和家庭用户特别有吸引力。记忆体储存、蓝牙连接和易于阅读的显示器等功能的便利性进一步推动了它们的采用。

随着高血压管理意识的增强，对数位血压计的需求可能会继续上升，巩固其在市场上的主导地位。手动血压计细分市场在 2023 年创造了 14 亿美元的收入，主要归功于其长期的可靠性和成本效益。手动设备在临床环境中经常受到青睐，允许医疗保健专业人员透过听诊获得精确的血压读数，确保准确性。它们广泛应用于易于获得培训和专业知识的医院和诊所。

此外，手动血压计不需要电池或电力，使其成为各种环境下的实用选择。可靠性和实用性的结合有助于巩固他们在市场中的地位。北美血压计市场在 2023 年达到 6.407 亿美元，在高血压盛行率高和心血管健康意识增强的推动下，2024 年至 2032 年将以 6.1% 的复合年增长率增长。该地区受益于先进的医疗基础设施和广泛的医疗技术，促进了数位和手动血压计的采用。由于专注于创新和优质医疗保健，北美将成为血压计行业整体成长的关键贡献者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 包括高血压在内的心血管疾病发生率上升
    • 医疗机构平均患者就诊次数增加
    • 血压计的技术进步
    • 不断增长的老年人口池
  • 产业陷阱与挑战
    • 严格的监管审批和合规性
• 成长潜力分析
• 监管环境
• 2023 年定价分析
• 技术景观
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 数位血压计
  • 手臂式电子血压计
  • 腕式电子血压计
• 无液体血压计
• 水银血压计

第 6 章：市场估计与预测：按营运情况，2021 - 2032 年

• 主要趋势
• 手动的
• 自动的
• 半自动

第 7 章：市场估计与预测：按配置，2021 - 2032 年

• 主要趋势
• 便携的
• 桌面安装式
• 落地式
• 壁挂式

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 居家护理
• 门诊手术中心
• 其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• A&D Company, Limited
• ACCOSON
• American Diagnostic Corporation
• Beurer GmbH
• Bosch + Sohn GmbH & Co. KG
• BPL Medical Technologies Pvt. Ltd.
• GE Healthcare
• Little Doctor International (S) Pte. Ltd.
• Microlife Corporation
• Omron Healthcare, Inc.
• Prestige Medical
• Rudolf Riester GmbH
• Rossmax International Ltd.
• Spengler SAS
• SunTech Medical, Inc.

The Global Sphygmomanometer Market was worth USD 3.4 billion in 2023 and is anticipated to exhibit an 8.5% CAGR from 2024 to 2032, attributed to the rising incidence of cardiac conditions, advancements in technology, and the ongoing launch of innovative products. As hypertension becomes increasingly common, there is a growing demand for accurate and reliable blood pressure monitoring devices. Technological innovations, such as digital sphygmomanometers with automated readings and connectivity features, enhance user experience and data management. Also, ongoing improvements in design and functionality are making these devices more accessible and efficient, further propelling the market's expansion in both clinical and home settings.

The sphygmomanometer industry is segregated based on product, operation, configuration, end-use, and region. The digital sphygmomanometer segment achieved USD 2 billion in 2023, owing to its user-friendly design and enhanced accuracy. Digital devices offer automatic readings, which eliminate manual errors and provide quicker results, making them particularly appealing for both healthcare professionals and home users. The convenience of features such as memory storage, Bluetooth connectivity, and easy-to-read displays further drives their adoption.

As awareness of hypertension management grows, the demand for digital sphygmomanometers is likely to continue rising, solidifying their dominance in the market. The manual sphygmomanometer segment generated USD 1.4 billion in 2023, primarily due to its longstanding reliability and cost-effectiveness. Often favored in clinical settings, manual devices allow healthcare professionals to take precise blood pressure readings through auscultation, ensuring accuracy. They are widely used in hospitals and clinics where training and expertise are readily available.

Besides, manual sphygmomanometers do not require batteries or electricity, making them a practical choice in various environments. This combination of reliability and practicality helps reinforce their position in the market. North America sphygmomanometer market witnessed USD 640.7 million in 2023 and will grow at a 6.1% CAGR between 2024 and 2032, driven by a high prevalence of hypertension and increased awareness of cardiovascular health. The region benefits from advanced healthcare infrastructure and widespread access to medical technologies, facilitating the adoption of both digital and manual sphygmomanometers.Furthermore, ongoing initiatives to improve chronic disease management and promote preventive healthcare are further boosting demand. With a focus on innovation and quality healthcare, North America will stand as a key contributor to the overall growth of the sphygmomanometer industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of cardiovascular disorders including hypertension
    • 3.2.1.2 Increase in average patient visits in healthcare settings
    • 3.2.1.3 Technological advancements in sphygmomanometers
    • 3.2.1.4 Growing geriatric population pool
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory approvals and compliance
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing analysis, 2023
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Digital sphygmomanometer
  • 5.2.1 Arm electronic sphygmomanometer
  • 5.2.2 Wrist electronic sphygmomanometer
• 5.3 Aneroid sphygmomanometer
• 5.4 Mercury sphygmomanometer

Chapter 6 Market Estimates and Forecast, By Operation, 2021 - 2032 ($ Mn and Units)

• 6.1 Key trends
• 6.2 Manual
• 6.3 Automatic
• 6.4 Semi-automatic

Chapter 7 Market Estimates and Forecast, By Configuration, 2021 - 2032 ($ Mn and Units)

• 7.1 Key trends
• 7.2 Portable
• 7.3 Desk mounted
• 7.4 Floor standing
• 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn and Units)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Homecare
• 8.4 Ambulatory surgical centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 A&D Company, Limited
• 10.2 ACCOSON
• 10.3 American Diagnostic Corporation
• 10.4 Beurer GmbH
• 10.5 Bosch + Sohn GmbH & Co. KG
• 10.6 BPL Medical Technologies Pvt. Ltd.
• 10.7 GE Healthcare
• 10.8 Little Doctor International (S) Pte. Ltd.
• 10.9 Microlife Corporation
• 10.10 Omron Healthcare, Inc.
• 10.11 Prestige Medical
• 10.12 Rudolf Riester GmbH
• 10.13 Rossmax International Ltd.
• 10.14 Spengler SAS
• 10.15 SunTech Medical, Inc.